Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 26, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically…
